Abstract Purpose of the Review There have been increasing reports of cardiovascular
complications of androgen deprivation therapy (ADT) leading to worse outcomes among …

Prostate cancer is the second most common form of cancer in men. For advanced, high risk
prostate cancer, androgen deprivation therapy (ADT) is the preferred treatment and can …

Prostate cancer (PCa) represents the second most common cancer in men and affects
millions worldwide. Chemotherapy is a common treatment for PCa but the development of …

Primary prostate cancer (PC) progresses to castration-resistant PC (CRPC) during androgen
deprivation therapy (ADR) in early stages of prostate cancer. Thus, rather than blocking the …

Background and objective Gonadotropin-releasing hormone (GnRH) antagonists and
agonists are cornerstone treatments in prostate cancer. However, evidence regarding the …

Simple Summary Androgen deprivation therapy alone is commonly performed for metastatic
prostate cancer but is generally not recommended for the treatment of high-risk localized or …

Background Echinococcus multilocularis causes alveolar echinococcosis (AE), a rising
zoonotic disease in the northern hemisphere. Treatment of this fatal disease is limited to …

Cardiometabolic side effects of androgen deprivation therapy... : Current Opinion in Supportive
and Palliative Care Cardiometabolic side effects of androgen deprivation therapy in prostate …

Background The outcomes of metastatic hormone-sensitive prostate cancer (mHSPC) have
significantly improved through treatment intensification, yet Black representation in those …

The aberrant activation of HER2 has a pivotal role in bone metastasis implantation and
progression in several tumor types, including prostate cancer (PC). Trastuzumab and other …